Recent Research Funding

Tom Russo, MD.

More than $2 million in annual extramural funding goes to researchers in our division, including Thomas Russo, MD.

Faculty research is supported by extramural funding of more than $2 million annually. The majority of support is derived from national funding agencies such the National Institutes of Health, the Department of Defense and the Veterans Administration.

  • The Role of Exosomes in the Pathogenesis of Gulf War Respiratory Illness. John Hu (Principal Investigator). VA BLR&D. $969,511. 10/1/2025-9/1/2029.
  • Determining the value of PBP 7/8 as an antimicrobial target for XDR-A. baumannii. Thomas Russo (Principal Investigator). Veterans Administration. $1,359,244. 10/1/2019-9/1/2027.
  • Mab Passive Vaccination against Acinetobacter baumannii. Thomas Russo (Co-Investigator). NIAID/NIH. $485,053. 9/1/2022-8/1/2027.
  • Novel Combination Therapies to Combat Hypermutable Carbapenem-Resistant P. aeruginosa. Thomas Russo (Co-Investigator). NIAID/NIH. 5/1/2022-4/1/2027.
  • Determining Virulence of C. acnes Shoulder PeriProsthetic Joint Infection Isolates. John Crane (Co-Investigator). American Shoulder and Elbow Surgeons. $10,000. 2/1/2025-2/1/2026.
  • HPV and HIV Co-infection: Clinical, Socio-Behavioral and Microbiome Implications. Jonathan Claus (Co-Principal Investigator). NIH. $900,368. 9/1/2022-9/1/2024.
  • Identification of new or unrecognized virulence genes in hypervirulent Klebsiella pneumoniae and antivirulence genes in classical K. pneumoniae. Thomas Russo (Principal Investigator). NIH. $431,682. 8/1/2020-7/1/2024.